Inorganic materials as drug delivery systems in coronary artery stenting

Materialwissenschaft und Werkstofftechnik

Volumn 33, Issue 12, 2002, Pages 738-746

  Karoussos, Ira A ^a   Wieneke, H ^a   Sawitowski, T ^a   Wnendt, S ^a   Fischer, A ^b   Dirsch, O ^a   Dahmen, U ^a   Erbel, R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Biomaterials; Coatings; Restenosis; Stents

Indexed keywords

BIOCOMPATIBILITY; CARDIOVASCULAR SYSTEM; DRUG THERAPY; INORGANIC COATINGS;

CORONARY ARTERY STENTING;

BIOMATERIALS;

EID: 0036993531     PISSN: 09335137     EISSN: None     Source Type: Journal    
DOI: 10.1002/mawe.200290004     Document Type: Article

References (84)

1. Alt, E., Haehnel, I., Beilharz, C., Prietzel, K., Preter, D., Stemberger, A., Fliedner, T., Erhardt, W., Schömig, A., Inhibition of neointima formation after experimental coronary artery stenting. A new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 101 (2000) 1453-1458.
2. Amento, E. P., Ehsani, N., Palmer, H., Libby, P., Cytokines positively and negatively regulate interstitial collagen genes expression in human vascular smooth muscle cells. Arteriosclerosis 11 (1991) 1223-1230.
3. Aggarwal, R. K., Ireland, D. C., Azrin, M. A., Ezekowitz, M. D., de Bono, D. P., Gershlick, A. H., Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 94(12) (1996) 3311-3317.
4. Antoniucci, D., Bartorelli, A., Valenti, R., Montorsi, P., Santoro, G. M., Fabbiocchi, F., Bolognese, L., Loaldi, A., Trapani, M., Trabattoni, D., Moschi, G., Galli, S., Clinical and angiographic outcome after coroanry stenting with the carbostent. Am J Cardiol 85 (2000) 821-825.
5. Antoniucci, D., Valenti, R., Migliorini, A., Moschi, G., Trapani, M., Bolognese, L., Santoro, G. M., Cerisano, G., Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure. Catheter Cardiovasc Interv 54 (2001) 420-426.
6. Armstrong, J., Gunn, J., Arnold, N., Malik, N., Chan, K. H., Vick, T., Stratford, P., Cumberalnd, D. C., Holt, C. M., Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries. J Invasive Cardiol 14(5) (2002) 230-238.
7. Atalar, E., Haznedaroglu, I., Aytemir, K., Aksoyek, S., Ovune, K., Oto, A., Ozmen, F., Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation. Clin Cardiol 24 (2001) 159-164.
8. Baldus, S., Kösten R., Elsner, M., Walter, D. H., Arnold, R., Auch-Schwelk, W., Berger, J., Rau, M., Meinertz, T., Zeiher, A. M., Hamm, C. W.,. Treatment of aortocoronary vein graft lesions with membrane-covered stents. Circulation 201 (2000) 2024-2027.
9. Bei Ping, Q., Yanming, H., Wang, L., Vermeire, I., Verbeken, E., Schacht, E., De Scheerder, I. K., Methylprednisolon coated dedrease neointimal hyperplasia in a porcine coronary model. J Am Coll Cardiol 37 (suppl.) (2001) 74A.
10. Bertrand, O. F., Sipehia, R., Mongrain, R., Rodes, J., Tardif, J. C., Bilodeau, L., Cote, G., Bourassa, M. G., Biocompatibility aspects of new stent technology. J Am Coll Cardiol 32 (1998) 562-571.
11. Boland, J. L., Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study, Int J Cardiovasc Intervent 3 (2000) 215-225.
12. Cardiovascular Group, Clinical Sciences Centre, Northern General Hospital, Sheffield, UK. Biomimicry 1: PC. Semin Interv Cardiol 1998 Sep-Dec 3(3-4) 149-50.
13. Carter, A. J., Scott, D., Laird, J. R., Bailey, L., Kovach, J. A., Hoopes, T., G., Pierce, K., Heath, K., Hess, K., Farb, A., Virmani, R., Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn 1998 Jun, 44(2) 193-201.
14. Cenni, E., Granchi, D., Arciola, C. R., Ciapetti, G., Savarino, L., Stea, S., Cavedagna, D., Di Leo, A., Pizzoferrato A., Adhesive protein expression on endothelial cells after contact in vitro with polyethylene terephtalate coated with pyrolytic carbon. Biomaterials 16 (1995) 1223-1227.
15. Cremonesi, A., Benit, E., Carlier, M., Colombo, A., Piva, R., Probst, P., Wirtzfeld, A., Pico-Bourdonnec, C., Corcos, T., Multicenter registry to evaluate the efficacy of the NIROYAL stent in de novo or restenotic coronary stenosis. J Invasive Cardiol 12 (2000) 225-232.
16. De Scheerder, I., Szilard, M., Yanming, H., Ping, X. B., Verbeken, E., Neerinck, D., Demeyere, E., Coppens, W., Van de Werf, F., Evaluation of the biocompatibility of two new diamond-like stent coating (Dylyn) in a porcine coronary stent model. J Invasive Cardiol 12 (2000) 389-394.
17. De Scheerder, I., Wang, K., Wilczek, K., Meuleman, D., Van Amsterdam, R., Vogel, G., Piessens, J., Van de Werf, F., Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 95 (1997) 1549-1553.
18. De Scheerder, I. K., Wilczek, K. L., Verbeken, E. V., Vandorpe, J., Lan, P. N., Schacht, E., De Geest, H., Piessens, J., Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 114 (1995) 105-114.
19. Degertekin, M., Regar, E., Tanabe, K., Sousa, J. E., Colombo, A., Guagliumi, G., Guermonptrez, J. L., de Feyter, P., Morice, M. C., Serruys, P. W., Incidence of incomplete stent apposition at six months follow-up in the multi center RAVEL trial. J Am Coll Cardiol 39 (suppl.) (2002) 38A.
20. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 86 (1992) 100-110.
21. Drachman, D. E., Edelman, E. R., Seifert, P., Groothuis, A. R., Bornstein, D. A., Kamath, K. R., Palasis, M., Yang, D., Nott, S. H., Rogers, C., Neointimal thickening after stent delivery of paclitaxel: Change in composition and arrest of growth over six months. J Am Coll Cardiol 36 (2000) 2325-2332.
22. Edelman, E. R., Seifert, P., Groothius, A., Morss, A., Bornstein, D., Rogers, C., Gold-coated NIR stents in porcine coronary arteries. Circulation 193 (2001) 429-434.
23. Erbel, R., Haude, M., Hopp, H. W., Franzen, D., Rupprecht, H. J., Heublein, B., Fischer, K., de Jaegere, P., Serruys, P., Rutsch, W., Probst, P., Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med 339 (1998) 1672-1678.
24. Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., Reidy, M. A., Role of platelets in smooth muscle cell proliferation and migration after injury. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 54 (1986) 293-303.
25. Fischer, A., Wieneke, H., Brauer, H., Erbel, R., Metallic biomaterials for coronary stents. Z Kardiol 4 (2001) 251-262.
26. Fishman, D. L., Leon, M. B., Baim, D. S., Schwatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., Cleman, M., Heuser, R., Almond, D., Teirstein, P. S., Fish, D., Colombo, A., Brinker, J., Moses, J., Shaknovich, A., Hirshfeld, J., Bailey, S., Ellis, S., Rake, R., Goldberg, S., A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331 (1994) 496-501.
27. Galli, M., Bartorelli, A., Bedogni, F., DeCesare, N., Klugmann, S., Maiello, S., Miccoli, F., Moccetti, T., Onofri, M., Paolillo, V., Pirisi, R., Presbitero, P., Sganzerla, P., Viecca, M., Zerboni, S., Lanteri, G., Italian BiodivYsio registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent, J Invasive Cardiol 12 (2000) 452-458.
28. George, B. S., Voorhees III, W. D., Roubin, G. S., Fearnot, N. E., Pinkerton, C. A., Raizner, A., King, S. B., Holmes, D. R., Topol, E. J., Kereiakes, D. J., Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes. J Am Coll Cardiol 22 (1993) 135-143.
29. Gershlick, A. H., De Scheerder, I., Chevalier, B., Camenzind, E., Gommeaux, A., Vrints, C., Reifart, N., Missault, L., Goy, J.-J., Brinker, J. A., Stepehns-Lloyd, A., Heldman, A. W., Circulation 104 (suppl.) (2001) II416.
30. Gobeil, F., Laflamme, M., Bouchard, M., Campbell, E., Wood, M., St-Jacques, P., Vincent, J., Leclerc, G., BiodivYsio stent coated with metalloproteinase inhibitor reduces neointimal hyperplasia in a procine coronary artery restenosis model. Circulation 104 (suppl.) (2001) II388.
31. Grube, E., Silber, S. M., Hauptmann, K. E., TAXUS I: Prospective, randomized, double-blind comparison of NIRx™ stents coated with paclitaxel in a polymer carrier in de-novo coronary lesions compared with uncoated controls. Circulation 104 (suppl.) (2001) II312.
32. Gruentzig, A. R., Senning, A., Siegenthaler, W. E., Non-operative dilatation of coronary artery stenosis - percutaneous transluminal coronary angioplasty, N Engl J Med 301 (1979) 61-67.
33. Gutensohn, K., Beythien, C., Bau, J., Fenner, T., Grewe, P., Koester, R., Padmanaban, K., Kuehnl. In vitro analyses of diamond-like carbon coated stents: reduction of metal ion release, platelet activation, and thrombogenicity. Thomb Res 99 (2000) 577-585.
34. Haase, J., Störger, H., Hofmann, M., Braun, Schwarz, C.-E., Reinemer, H., Schwarz, F., Bewirkt die Beschichtung von koronaren Edelstahlstents mit turbostratischem Carbon eine Reduktion von klinischen Ereignissen und In-Stent-Restenosen? Ergebnisse einer prospektiven randomisierten Vergleichsstudie. Z Kardiol 91 (suppl.) (2002) I/66.
35. Haude, M., Erbel, R., Issa, H., Meyer, J., Quantitative analysis of elstic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stems. J Am Coll Cardiol 27 (1993) 26-34.
36. Hehrlein, C., Zimmermann, M., Metz, J., Ensinger, W., Kübler, W., Influence of surface texture and charge on the biocompatibility of endovascular stents. Coron Artery Dis 6 (1995) 581-586.
37. Heublein, B., Pethig, K., Elsayed, A. M., Silicon carbide coating - a semiconducting hybrid design of coronary stents - a feasibility study. J Invasive Cardiol 10 (1998) 255-262.
38. Kaluza, C. L., Raizner, A. E., Park, S. J., Shim, W. H., Ho, D. S., Voorhees, W. D., Fearnot, N. E., Dramatic inhibition of neointimal proliferation by the paclitaxel-eluting stents showing radiation-like results without radiation: insights from the QCA core laboratory. J Am Coll Cardiol 39 (suppl.) (2002) 26A.
39. Kandzari, D. E., Tcheng, J. E., Zidar, J. P., Coronary artery stents: evaluating new designs for contemporary percutaneous intervention. Catheter Cardiovasc Interv 56 (2002) 562-576.
40. Karas, S. P., Gravanis, M. B., Santoian, E. C., Robinson, K. A., Andernerg, K. A., King, S. B., III. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol 20 (1992) 467-474.
41. Kastrati, A., Schömig, A., Dirschinger, J., Mehilli, J., von Welser, N., Pache, J., Schühlen, H., Schilling, T., Schmitt, C., Neumann, F. J., Increased risk of restenosis after placement of gold-coated stents. Circulation 101 (2000) 2478-2483.
42. Klein, C. L., Nieder, P., Wagner, M., Köhler, H., Bittinger, F., Kirkpatrick, C. J., Lewis, J. C., The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions. J Pathophysiol 5 (1994) 798-807.
43. Komatsu, R., Ueda, M., Naruko, T., Kojima, A., Becker, A. E., Neointimal tissue response at sites of coronary stenting in humans. Circulation 98 (1998) 224-233.
44. Konorwski, R., Hong, M. K., Tio, F. O., Bramwell, O., Wu, H., Leon, M. B., In-stent restenosis contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224-230.
45. Liistro, F., Stankovic, G., Di Mario, C., Takagi, T., Chieffo, A., Moshiri, S., Montorfano, M., Carlino, M., Briguori, C., Pagnotta, P., Albiero, R., Corvaja, N., Colombo, A., First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis. Circulation 105 (2002) 1883-1886.
46. Lincoff, A. M., Furst, J. G., Ellis, S. G., Tuch, R. J., Topol, E. J., Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 29 (1997) 808-816.
47. Liu, X., Huang, Y., De Scheerder, on behalf of the STRIDE investigators. Study of antirestenosis with the Biodivysio Dexamethasone eluting stent (STRIDE): a multicenter trial. J Am Coll Cardiol 39 (suppl.) (2002) 15A.
48. Lyman, D. J., Fazzio, J., Voorhees, H., Robinson, G., Albo, D. Jr., Compliance as a factor affecting the patency of a copolyurethane vascular graft. J Biomed Mater Res 12 (1978) 337-345.
49. Malik, N., Gunn, J., Shepherd, L., Crossman, D. C., Cumberland, D. C., Holt, C. M., Phosphorylcholine-coated stents in procine coronary arteries: in vivo assessment of biocompatibility. Invasive Cardiol 13 (2001) 193-201.
50. Morice, M. C., Serruys, P. W., Sousa, J. E., Fajadet, J., Hayashi, E. B., Perin, M., Colombo, A., Schuler, G., Barrgan, P., Guagliumi, G., Molnar, F., Falotico, R., A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780.
51. Murphy, J. G., Schwanz, R. S., Edwards, W. D., Camrud, A. R., Vlietstra, R. E., Holmes, D. R. Jr., Percutaneous polyester stents in porcine coronary arteries: initial experience with polyethylene terephthalate stents. Circulation 86 (1992) 1596-1604.
52. Ozbek, C., Heisel, A., Cross, B., Bay, W., Schieffer, H., Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation. Cathet Cardiovasc Diagn May 41(1) (1997) 71-78.
53. Powell, J., Clozel, J., Muller, R., Kuhn, H., Hosang, M., Baumgartner, H. R., Inhibitors of angiotensin-conveiting enzyme prevent myointimal proliferation after vascular injury, Science 245 (1989) 186-188.
54. Ratner, B., Hoffmann, A., Schoen, F., Lemons, J. eds., An introduction to materials in medicine. San Diego, London, Boston, New York, Sydney, Tokyo, Toronto:Academic Press (1996).
55. Rechavia, E., Litvack, F., Fishbien, M. C., Nakamura, M., Eigler, N., Biocompatibility of polyurethane-coated stents: tissue and vascular aspects. Cath Cardiovasc Diagn 45 (1998) 202-207.
56. Revell, P., Braden, M., Weightman, B., Freeman, M., Experimental studies of the biological response to a new bone cement: II. Soft tissue reactions in the rat. Clin Mat 10 (1992) 233-238.
57. Rintoul, T. C., Butler, K. C., Thomas, D. C., Carriker, J. W., Maher, T. R., Kiraly, R. J., Massielo, A., Himley, S. C., Chen, J. F., Fukamachi, K., Continuing development of the Cleveland Clinic-Nimbus artificial heart. Am Soc Artif Intern Org 39 (1993) 168-171.
58. Robinson, K. A., Chronos, N. A. F., Royal, J., Su, L., Cipolla, G. D., Virmani, R., Stack, R. S., Actinomycin-D drug-eluting stents preserve lumen size and inhibit fibrocellular neointima in pig coronary arteries. Circulation 104 (suppl.) (2001) II506.
59. Rogers, C., Edelman, E., Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 91 (1995) 2995-3001.
60. Rzany, A., Harder, C., Schaldach, M., Silicon Carbide as an anti-thrombogenic stent coating; an example of a science-based development strategy. Prog Biomed Res 5 (2000) 168-177.
61. Scheller, B., Hennen, B., Severin-Kneib, S., Özbek, C., Schieffer, H., Markwirth, T., Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction. Am J Med 110 (2001) 1-6.
62. Schwanz, R. S., Holmes, D. R., Topol, E. J., The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 20 (1992) 1284-1293.
63. Schwanz, R. S., Huber, K. C., Murphy, J. G., Edwards, W. D., Camrud, A. R., Vlietstra, R. E., Holmes, D. R., Restenosis and proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19 (1991) 267-274.
64. Serruys, P. W., De Jaegere, P., Kiemeneij, F., Magaya, C., Rutsch, W., Hendrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., Belardi, J., Sigwart, U., Colombo, A., Goy, J. J., Van Den Heuvel, P., Delcan, J., Morel, M. A., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331 (1994) 489-495.
65. Sigwart, U., Puel, J., Mirkovich, V., Joffre, F., Kappenberger, L., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316 (1987) 701-705.
66. Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mottos, L. A., Sousa, A. G. M. R., Falotico, R., Jaeger, J., Popma, J. J., Serruys, P. W., Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195.
67. Sousa, J. E., Morice, M. C., Serruys, P. W., Fajadet, J., Perin, M., Hayashi, E. B., Colombo, A., Schuler, G., Barragan, P., Bode, C., The RAVEL study: a randomized study with the sirolimus coated BX velocity balloon expandable stent in the treatment of patients with de novo native coronary artery lesions. Circulation 104 (suppl.) (2001) II463.
68. Strauss, B. H., Chisholm, R. J., Keeley, F. W., Gotlieb, A. I., Logan, R. A., Armstrong. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 75 (1994) 650-658.
69. Suzuki, T., Kopia, G., Hayashi, S., Bailey, L. R., Llanos, G., Wilensky, R., Klugherz, B. D., Papandreou, G., Narayan, P., Leon, M. B., Yeung, A. C., Tio, F., Tsao, P. S., Falotico, R., Carter, A. J., Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193.
70. Tanigawa, N., Sawada, S., Kobayashi, M., Reaction of the aortic wall six metallic stent materials. Acad Radiol 2 (1995) 379-384.
71. Thornton, M. A., Gruentzig, A. R., Hollamn, J., King, S. B. 3rd, Douglas, J. S. Jr., Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 69 (1984) 721-727.
72. Topol, E. J., Leya, F., Pinkerton, C. A., Whilow, P. L., Hofling, B., Simonton, C. A., Masden, R. R., Serruys, P. W., Leon, M. B., Williams, D. O., King, S. B., Mark, D. B., Isner, J. M., Holmes, D. R., Ellis, S. J., Lee, K. L., Keeler, G. P., Berdon, L. G., Hinohara, T., Califf, R., A comparison of directional atherectomy with coronary angioplasty in patients with coronary disease: the Caveat Study Group. N Engl J Med 329 (1993) 221-225.
73. Unverdorben, M., Sippel, B., Degenhardt, R., Sattler, K., Fries, R., Abt, B., Wagner, E., Schatz, M., Koehler, H., Ibrahim, H., Tews, K. H., Hennen, B., Schieffer, H., Berthold, H. K., Vollbracht, C., Langzeitvergleich des Siliziumkarbid-beschichteten Stents mit einem Stahlstent: Die Tenax™ - vs. MIR™ Stent Studienresultate (RENISS-L). Z Kardiol 90 (suppl.) (2000) V/18.
74. van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M. M., Serruys, P. W., Holmes, D. R., Ellis, S. G., Topol, E. J., Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine arteries. Circulation 94 (1996) 1690-1697.
75. van der Giessen, W. J., Slager, C. J., van Beusekom, H. M. M., van Ingen Schenau, D. S., Huijts, R. A., Schuurbiers, J. C., de Klein, W. J., Serruys, P. W., Verdouw, P. D., Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J Intervent Cardiol 5 (1992) 175-185.
76. Virmani, R., Santarelli, A., Galloni, M., Pasquino, E., Bartorelli, A., Tissue response and biocompatibility of the Sorin Carbostent: experimental results in porcine coronary arteries. Am J Cardiol 82 (suppl.) (1998) A65.
77. Voigt, B. J., Pfitzner, P., Boeck, U., Paul, M., Der Mac-Stent: Erste Erfahrungen und Ergebnisse. Z Kardiol 89 (suppl.) (2000) VI/92.
78. Wanibuchi, H., Dingemans, K. P., Becher, A. E., Ueda, M., Naruko, T., Tanizawa, S., Nakamura, K., Is the Watanabe heritable hyperlipidemic rabbit a suitable experimental model for percutaneous transluminal coronary angioplasty in humans? A light microscopic, immunohistochemical and ultrastructural study. J Am Coll Cardiol 21 (1993) 1490-1496.
79. Whelan, D. M., van der Giessen, W. J., Krabben dam, S. C., van Vliet, E. A., Verdouw, P. D., Serruys, P. W., vanBeusekom, H. M. M., Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 83 (2000) 338-345.
80. Whitworth, H. B., Roubin, G. S., Hollman, J., Meier, B., Leimgruber, P. P., Douglas, J. S., King, S. B., Gruentzig, A. R., Effect of nifedipine on recurrent restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 8 (1986) 1271-1276.
81. Wieneke, H., Sawitowski, T., Wnendt, S., Dirsch, O., Gu, Y. L., Dahmen, U., Fischer, A., Erbel, R., Keramische Nanobeschichtung von koronaren Stents zur Reduktion der neointimalen Proliferation. Z Kardiol 91 (suppl.) (2002) I/66.
82. Windecker, S., Mayer, I., De Pasquale, G., Maier, W., Dirsch, O., De Croot, P., Wu, Y. P., Noll, G., Leskosek, D., Meier, B., Hess, O. M., Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation Aug 21 104(8) (2001)928-933.
83. Yachia, D., Aridogan, I. A., Comparison between first-generation (fixed-caliber), and second-generation (self-expanding, large caliber) temporary prostatic stents. Urol Int 57 (1996) 165-169.
84. Yamawaki, T., Shimokawa, H., Kozai, T., Miyata, K., Higo, T., Tanaka, E., Egashira, K., Shiraishi, T., Tamai, H., Igaki, K., Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent sppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 32 (1998) 780-786.